Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Cost savings of patients with a MACIS score lower than 6 when radioactive iodine is not given.

Pace-Asciak PZ, Payne RJ, Eski SJ, Walfish P, Damani M, Freeman JL.

Arch Otolaryngol Head Neck Surg. 2007 Sep;133(9):870-3.

PMID:
17875852
2.

Advances in the medical management of differentiated thyroid carcinoma and their impact on the surgical approach.

Van den Bruel A, Vauterin T, Poorten VV, Decallonne B.

Acta Chir Belg. 2007 Jun;107(3):271-8. Review.

PMID:
17685252
3.

External radiotherapy of thyroid cancer.

Pöllinger B, Dühmke E.

Onkologie. 2001 Apr;24(2):134-8. Review.

PMID:
11441292
4.

[CME: Radioactive iodine therapy in thyroid cancer].

Steinert HC, Aberle S.

Praxis (Bern 1994). 2015 Nov 11;104(23):1235-43; quiz 1244-5. doi: 10.1024/1661-8157/a002189. Review. German.

PMID:
26558927
6.

Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.

Patel SS, Goldfarb M.

J Surg Oncol. 2013 May;107(6):665-72. doi: 10.1002/jso.23295. Epub 2012 Nov 28. Review.

PMID:
23192391
7.

Cost-effective management of low-risk papillary thyroid carcinoma.

Shrime MG, Goldstein DP, Seaberg RM, Sawka AM, Rotstein L, Freeman JL, Gullane PJ.

Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1245-53. Review.

PMID:
18086967
8.

[Differentiated thyroid cancers].

Gorgone S, Campennì A, Calbo E, Catalfamo A, Sciglitano P, Sofia L, Niceta M, Borzì R, Calbo L.

G Chir. 2009 Jan-Feb;30(1-2):26-9. Review. Italian.

PMID:
19272228
9.

The role of external beam radiotherapy in the treatment of papillary thyroid cancer.

Lee N, Tuttle M.

Endocr Relat Cancer. 2006 Dec;13(4):971-7. Review.

10.

An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer.

Sawka AM, Brierley JD, Tsang RW, Thabane L, Rotstein L, Gafni A, Straus S, Goldstein DP.

Endocrinol Metab Clin North Am. 2008 Jun;37(2):457-80, x. doi: 10.1016/j.ecl.2008.02.007. Review.

PMID:
18502337
11.

The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008.

Sacks W, Fung CH, Chang JT, Waxman A, Braunstein GD.

Thyroid. 2010 Nov;20(11):1235-45. doi: 10.1089/thy.2009.0455. Review.

PMID:
21062195
12.

Radioactive iodine therapy.

Lee SL.

Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):420-8. doi: 10.1097/MED.0b013e328357fa0c. Review.

PMID:
22914564
13.

Management of invasive and advanced thyroid cancer.

Favia G, Iacobone M, Zanella S, Ciarleglio FA.

Minerva Endocrinol. 2009 Mar;34(1):37-55. Review.

PMID:
19209127
14.

Hyperparathyroidism after radioactive iodine therapy.

Colaço SM, Si M, Reiff E, Clark OH.

Am J Surg. 2007 Sep;194(3):323-7. Review.

PMID:
17693276
15.

[Treatment of differentiated thyroid cancer. Management of invasive cancer].

Squifflet JP.

Ann Endocrinol (Paris). 1997;58(3):225-8. Review. French. No abstract available.

PMID:
9239245
16.

Role of radioactive iodine for adjuvant therapy and treatment of metastases.

Jonklaas J.

J Natl Compr Canc Netw. 2007 Jul;5(6):631-40. Review.

PMID:
17623614
17.

Radioiodine in the treatment of thyroid cancer.

Van Nostrand D, Wartofsky L.

Endocrinol Metab Clin North Am. 2007 Sep;36(3):807-22, vii-viii. Review.

PMID:
17673129
18.

Patient misconceptions and ethical challenges in radioactive iodine scanning and therapy.

Rosenthal MS.

J Nucl Med Technol. 2006 Sep;34(3):143-50; quiz 151-2. Review.

Supplemental Content

Support Center